SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
Position in NRIX — Nurix Therapeutics, Inc.
CIK 1446179
BALA CYNWYD, PA
Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$341,459
-$994,382 QoQ
Shares Held
14,075
-88.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#143
of 210 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $18,967,826 across 42 Biotechnology names. NRIX ranks #17 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
91,886 | $5,257,716 | |
| 2 | NKTR |
Nektar Therapeutics
|
20,177 | $1,408,556 | |
| 3 | QURE |
uniQure N.V.
|
15,042 | $692,834 | |
| 4 | OLMA |
Olema Pharmaceuticals, Inc.
|
55,121 | $689,563 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
16,620 | $648,346 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
37,663 | $637,257 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
17,322 | $630,694 | |
| 8 | IMNM |
Immunome Inc.
|
26,035 | $551,681 |
All Filings in NRIX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,459 | 14,075 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $1,335,841 | 117,282 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,728,231 | 145,474 | Shares | Sole | 2025-05-14 | |
| 2022-03-31 | $459,093 | 32,769 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $870,844 | 30,081 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $942,002 | 31,442 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $272,904 | 8,300 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $314,190 | 9,000 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||